-
1
-
-
67651015956
-
Fetal hemoglobin chemical inducers for treatment of hemoglobinopathies
-
Testa U. Fetal hemoglobin chemical inducers for treatment of hemoglobinopathies. Ann Hematol. 2009;88:505-528.
-
(2009)
Ann Hematol
, vol.88
, pp. 505-528
-
-
Testa, U.1
-
2
-
-
34548016809
-
Developmental- and differentiation-specific patterns of human gamma- and beta-globin promoter DNA methylation
-
DOI 10.1182/blood-2007-01-068635
-
Mabaera R, Richardson CA, Johnson K, Hsu M, Fiering S, Lowrey CH. Developmental- and differentiation-specific patterns of human gamma- and beta-globin promoter DNA methylation. Blood. 2007;110:1343-1352. (Pubitemid 47281435)
-
(2007)
Blood
, vol.110
, Issue.4
, pp. 1343-1352
-
-
Mabaera, R.1
Richardson, C.A.2
Johnson, K.3
Hsu, M.4
Fiering, S.5
Lowrey, C.H.6
-
4
-
-
77955906235
-
Fetal globin gene inducers: Novel agents and new potential
-
Perrine SP, Castaneda SA, Chui DH, et al. Fetal globin gene inducers: novel agents and new potential. Ann N Y Acad Sci. 2010;1202:158-164.
-
(2010)
Ann N Y Acad Sci
, vol.1202
, pp. 158-164
-
-
Perrine, S.P.1
Castaneda, S.A.2
Chui, D.H.3
-
5
-
-
0000206049
-
5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons
-
DOI 10.1073/pnas.79.14.4428
-
DeSimone J, Heller P, Hall L, Zwiers D. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proc Natl Acad Sci U S A. 1982;79:4428-4431. (Pubitemid 12045807)
-
(1982)
Proceedings of the National Academy of Sciences of the United States of America
, vol.79
, Issue.14 I
, pp. 4428-4431
-
-
DeSimone, J.1
Heller, P.2
Hall, L.3
Zwiers, D.4
-
6
-
-
0036625004
-
Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia
-
DOI 10.1182/blood.V99.11.3905
-
DeSimone J, Koshy M, Dorn L, et al. Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia. Blood. 2002;99:3905-3908. (Pubitemid 35332025)
-
(2002)
Blood
, vol.99
, Issue.11
, pp. 3905-3908
-
-
DeSimone, J.1
Koshy, M.2
Dorn, L.3
Lavelle, D.4
Bressler, L.5
Molokie, R.6
Talischy, N.7
-
7
-
-
35548970109
-
Role of epigenetic modifications in normal globin gene regulation and butyrate-mediated induction of fetal hemoglobin
-
DOI 10.1182/blood-2007-02-076091
-
Fathallah H, Weinberg RS, Galperin Y, Sutton M, Atweh GF. Role of epigenetic modifications in normal globin gene regulation and butyrate-mediated induction of fetal hemoglobin. Blood. 2007;110:3391-3397. (Pubitemid 350106335)
-
(2007)
Blood
, vol.110
, Issue.9
, pp. 3391-3397
-
-
Fathallah, H.1
Weinberg, R.S.2
Galperin, Y.3
Sutton, M.4
Atweh, G.F.5
-
8
-
-
38149059827
-
Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells
-
Moutouh-de Parseval LA, Verhelle D, Glezer E, et al. Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells. J Clin Invest. 2008;118:248-258.
-
(2008)
J Clin Invest
, vol.118
, pp. 248-258
-
-
Moutouh-de Parseval, L.A.1
Verhelle, D.2
Glezer, E.3
-
9
-
-
35548943647
-
Thalidomide induces gamma-globin gene expression through increased reactive oxygen species-mediated p38 MAPK signaling and histone H4 acetylation in adult erythropoiesis
-
DOI 10.1182/blood-2007-01-065201
-
Aerbajinai W, Zhu J, Gao Z, Chin K, Rodgers GP. Thalidomide induces gamma-globin gene expression through increased reactive oxygen species-mediated p38 MAPK signaling and histone H4 acetylation in adult erythropoiesis. Blood. 2007;110:2864-2871. (Pubitemid 350006939)
-
(2007)
Blood
, vol.110
, Issue.8
, pp. 2864-2871
-
-
Aerbajinai, W.1
Zhu, J.2
Gao, Z.3
Chin, K.4
Rodgers, G.P.5
|